Covid-19

Our latest Research Highlights video features three exciting new findings from Whitehead Institute: New work from the Jaenisch lab helps explain bats' impressive resistance to viruses; researchers in the Young lab identify a common denominator underlying chronic disease states; and researchers in the Cheeseman lab identify precise regulatory mechanisms controlling the production of protein variants during mitosis.

Whitehead Institute Member Rudolf Jaenisch and colleagues took an interdisciplinary approach to develop a new stem cell-derived model of vascular cells, with which they identified how SARS-CoV-2 can cause vascular complications such as blood clots and strokes.

Bats rarely get sick from deadly viruses like Ebola and Nipah despite carrying them. Now, Whitehead Institute Founding Member Rudolf Jaenisch and colleagues have found that while the SARS-CoV-2 virus can enter bat cells, the innate immune system prevents it from replicating and hijacking the cell's machinery.

Whitehead Institute Founding Member Rudolf Jaenisch and colleagues found that SARS-Cov-2 can infect sensory neurons and alter their gene expression. This may help to explain the peripheral nervous system symptoms associated with Covid-19, such as loss of smell.

Research from Whitehead Institute Member Yukiko Yamashita’s lab finds that a retrotransposon, a genetic element often thought of as a parasite, actually plays an important role in rejuvenating an important region of DNA, preserving fertility in flies.

New research from Whitehead Institute Founding Member Rudolf Jaenisch’s lab adds evidence to their finding that SARS-CoV-2 can integrate into the human genome, but finds that a model of the mRNA vaccine does not integrate.

Unlike our own genomes, the genetic material of the novel coronavirus is RNA — and RNA also makes up some of the vaccines. Learn how the field of RNA biology has been working to meet the challenges of the virus, and what Whitehead Institute RNA researchers have been working on throughout the pandemic. 

A paper from the lab of Whitehead Institute Member Rudolf Jaenisch suggests that the genetic material of SARS-CoV-2 can integrate into the host cell genome and be expressed in some patient-derived tissues.